A Clinical Study To Assess Association Of Hypertensive Retinopathy In Patients Having Cerebral Stroke

Authors

  • Dr Sudebi Roy , Dr Radhika Paranjpe , Dr Megha Kotecha , Dr Renu Magdum

DOI:

https://doi.org/10.47750/pnr.2022.13.S06.573

Abstract

Aim: The aim of the study was to determine the prevalence and document the various grades ofhypertensive retinopathy in patients of stroke with hypertension.

Methods: The Descriptive cross-sectional study was conducted at Dr. D. Y. Patil Medical college, Pune from September 2020 to October 2022 and 100 patients were included in the study.

Results: Among the study population, 66.00% of them were male, 34.00% of them were female. Among the study population with grade, 32.00% of them had moderate, 31.00% of them had mild, 25.00% of them had none and 12.00% of them had severe grade. Among the study population, the mean age was 54.38 ± 9.27, the mean duration was 10.02 ± 5.17 and the mean SBP was 141.04 ± 16.31, the mean DBP was 84 ± 17.25. Among the study population, 61.00% of them had LVH, 54.00% of them had Putamen, 65.00% of them had Internal Capsule, 22.00% of them had thalamus, 10.00% of them had Cerebellum, 11.00% of them had pons, 3.00% of them had Lobar, 31.00% of them had With Ivh.

Conclusion: We found that Independent of other vascular risk factors, Hypertensive retinopathy is associated with an increased long-term risk of stroke, in people with hypertension who do not have diabetes. People with hypertensive retinopathy are also more likely to get a cerebral infarction even when their blood pressure appears to be under control.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

A Clinical Study To Assess Association Of Hypertensive Retinopathy In Patients Having Cerebral Stroke. (2022). Journal of Pharmaceutical Negative Results, 4345-4353. https://doi.org/10.47750/pnr.2022.13.S06.573